FL2021-001, Inc.
FL2021-001, Inc. is listed today as Alumis Inc.: market value, financials and filings are on its company page.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2024 | $40 M | No. 4 | $10 to $50 million | equity | SEC | |
| Mar 2024 | $130 M | No. 3 | $50 to $250 million | equity | SEC | |
| Mar 2021 | $60 M | No. 2 | $50 to $250 million | equity, debt, options | SEC | |
| Feb 2021 | $11 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Alumis Inc., its revenue in fiscal 2025 came from these product and service lines: License $17.39 million (72%), Collaboration $6.66 million (28%).
Annual report (SEC XBRL) · Dec 2025
FL2021-001, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).
SEC Form D · Jul 2024
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2024
Products and services#
No products or services of FL2021-001, Inc. are on record.
Investors#
12 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | Fund or asset manager | not stated | not stated | Held Series B, B-2 and C preferred stock, 10% owner, director (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Fund VI LP | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Fund V, L.P. | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Management VI LLC | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Management V, LLC | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Opportunity Fund V, L.P. | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Capital Opportunity Management V, LLC | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Labs Affiliates 2021, LLC | Other | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Labs Fund I, L.P. | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Labs, LLC | Other | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Foresite Labs Management I, LLC | Fund or asset manager | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
| Labs Co-Invest V, LLC | Other | not stated | not stated | Held Series Seed, A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2024) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 24 investors.
Largest shareholders today
Institutions holding Alumis Inc. shares, as of Sep 30, 2026.
- AyurMaya Capital Management Company, LP$112 M—
- BlackRock, Inc.$63 M—
- Deep Track Capital, LP$55 M—
- Samsara Biocapital, LLC$53 M—
- Foresite Capital Management V, LLC$44 M—
- Nextech Invest Ltd.$34 M—
- Vanguard Capital Management LLC$31 M—
- Foresite Capital Management VI LLC$31 M—
- venBio Partners LLC$31 M—
- Millennium Management LLC$25 M—
- State Street Corp$22 M—
- Saturn V Capital Management LP$21 M—
- Citadel Advisors LLC$18 M—
- Morgan Stanley$16 M—
- Cormorant Asset Management, LP$15 M—
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David M. Goldstein | Executive officer | Jul 2024 |
| Derrick R. Richardson | Executive officer | Jul 2024 |
| John R. Schroer | Executive officer | Jul 2024 |
| Jorn Drappa | Executive officer | Jul 2024 |
| Mark Bradley | Executive officer | Jul 2024 |
| Martin Babler | Executive officer | Jul 2024 |
| Roy C. Hardiman | Executive officer | Jul 2024 |
| Sara R. Klein | Executive officer | Jul 2024 |
| June Lee | Executive officer | Mar 2021 |
| Alan B. Colowick | Director | Jul 2024 |
| James B. Tananbaum | Director | Jul 2024 |
| Martin Babler | Director | Jul 2024 |
| Patrick B. Machado | Director | Jul 2024 |
| Sapna B. Srivastava | Director | Jul 2024 |
| Srinivas R. Akkaraju | Director | Jul 2024 |
| Zhengbin B. Yao | Director | Jul 2024 |
| Alan Colowick | Director | Mar 2024 |
| James Tananbaum | Director | Mar 2024 |
| Julian Baker | Director | Mar 2024 |
| Richard Gaster | Director | Mar 2024 |
| Sapna Srivastava | Director | Mar 2024 |
| Srinivas Akkaraju | Director | Mar 2024 |
| Zhengbin Yao | Director | Mar 2024 |
| June Lee | Director | Mar 2021 |
| Michael Rome | Director | Mar 2021 |
| Vikram Bajaj | Director | Feb 2021 |
Went public since 2024. Its SEC number is that of a company listed on a stock exchange.